Paolo Tarantino: Neoadjuvant THP x12 Set to Become New SoC for Stage II HER2+ Breast Cancer
Paolo Tarantino, Research Fellow Dana-Farber Cancer Institute and Harvard Medical Schoolpost, shared a post on X: “Neoadjuvant THP x12 will likely soon become a SoC for many patients with stage II […]
Read the full articleYou might also wanna read
Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer
Conditions : Breast Cancer (Triple Negative Breast Cancer (TNBC)) Interventions : Other: Non interventional study Sponsors : Assistance Publ
Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study
Conditions : Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; HER2-positive Gastric Cancer Interventions : Drug: Zanidatamab; Drug:
<![CDATA[20 On the Upswing: A Retrospective Cohort Study Evaluating Neoadjuvant Chemotherapy Response in Metaplastic Breast Cancer Patients]]>
New plasma proteomics model improves thrombosis risk prediction in cancer patients and identifies IL-17-driven endothelial activation as therapeutic target
Thrombosis remains a major cause of morbidity and mortality in patients with cancer. Existing risk models fail to reliably predict venous th
scim.ag·18d ago
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
El V Oncocongreso de Alicante abordará los últimos avances en el tratamiento contra el cáncer
El evento tendrá lugar el 28 de noviembre para poner en el centro del debate la atención multidisciplinar a pacientes oncológicos
A Study of TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE in Participants With Incurable Hepatocellular Carcinoma
Conditions : Hepatocellular Carcinoma Interventions : Drug: SHR-8068+ Adebrelimab+ Bevacizumab; Drug: SHR-8068 Placebo+ Adebrelimab Placebo+
Comments
Sign in to join the conversation.
No comments yet. Be the first.